Findings from a population-based study in northern Sweden suggest that the risk of stroke may be linked to a certain type of antibody in the immune system.
Low levels of natural immunoglobulin M (IgM) antibodies specific for phosphorylcholine (anti-PC) have been identified as a novel independent risk marker for development of stroke. Results of a population-based study from northern Sweden, published online ahead of print February 11 by Stroke, suggest that measurements of IgM anti-PC could be used to identify immunodeficient subjects at increased risk for stroke.
More Headlines